Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

Fund Overview

Fund Size

₹200 Cr

Expense Ratio

0.54%

ISIN

INF754K01LV5

Minimum SIP

₹100

Exit Load

No Charges

Inception Date

26 Oct 2020

About this fund

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is a Index Funds mutual fund schemes offered by Edelweiss Mutual Fund. This fund has been in existence for 5 years, 10 months and 23 days, having been launched on 26-Oct-20.
As of 16-Sep-26, it has a Net Asset Value (NAV) of ₹24.41, Assets Under Management (AUM) of 199.62 Crores, and an expense ratio of 0.54%.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has given a CAGR return of 16.36% since inception.
The fund's asset allocation comprises around 99.88% in equities, 0.00% in debts, and 0.12% in cash & cash equivalents.
You can start investing in Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+19.38%

— (Cat Avg.)

3 Years

+18.46%

— (Cat Avg.)

5 Years

+13.33%

— (Cat Avg.)

Since Inception

+16.36%

— (Cat Avg.)

Portfolio Summaryas of 31st August 2026

Equity	₹199.38 Cr	99.88%
Others	₹0.24 Cr	0.12%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹21.94 Cr	10.99%
Divi's Laboratories Ltd	Equity	₹13.89 Cr	6.96%
Eli Lilly and Co	Equity	₹12.66 Cr	6.34%
Apollo Hospitals Enterprise Ltd	Equity	₹11 Cr	5.51%
Max Healthcare Institute Ltd Ordinary Shares	Equity	₹9.03 Cr	4.52%
Torrent Pharmaceuticals Ltd	Equity	₹8.88 Cr	4.45%
Cipla Ltd	Equity	₹8.74 Cr	4.38%
Johnson & Johnson	Equity	₹8.73 Cr	4.37%
Laurus Labs Ltd	Equity	₹8.25 Cr	4.14%
Dr Reddy's Laboratories Ltd	Equity	₹7.1 Cr	3.56%
AbbVie Inc	Equity	₹6.18 Cr	3.10%
Lupin Ltd	Equity	₹6.14 Cr	3.08%
Aurobindo Pharma Ltd	Equity	₹5.51 Cr	2.76%
Fortis Healthcare Ltd	Equity	₹5.47 Cr	2.74%
Merck & Co Inc	Equity	₹4.98 Cr	2.49%
Glenmark Pharmaceuticals Ltd	Equity	₹4.3 Cr	2.15%
Novartis AG ADR	Equity	₹3.8 Cr	1.90%
Ipca Laboratories Ltd	Equity	₹3.38 Cr	1.70%
Biocon Ltd	Equity	₹3.28 Cr	1.64%
Amgen Inc	Equity	₹3.16 Cr	1.58%
Thermo Fisher Scientific Inc	Equity	₹3.13 Cr	1.57%
Mankind Pharma Ltd	Equity	₹3.07 Cr	1.54%
Alkem Laboratories Ltd	Equity	₹2.74 Cr	1.37%
Zydus Lifesciences Ltd	Equity	₹2.66 Cr	1.33%
Gland Pharma Ltd	Equity	₹2.63 Cr	1.32%
Abbott Laboratories	Equity	₹2.62 Cr	1.31%
Gilead Sciences Inc	Equity	₹2.48 Cr	1.24%
Aster DM Quality Care Ltd Ordinary Shares	Equity	₹2.17 Cr	1.08%
Novo Nordisk AS ADR	Equity	₹1.99 Cr	1.00%
Ajanta Pharma Ltd	Equity	₹1.93 Cr	0.97%
Vertex Pharmaceuticals Inc	Equity	₹1.89 Cr	0.95%
Danaher Corp	Equity	₹1.86 Cr	0.93%
Intuitive Surgical Inc	Equity	₹1.82 Cr	0.91%
Medtronic PLC	Equity	₹1.59 Cr	0.79%
Stryker Corp	Equity	₹1.52 Cr	0.76%
Global Health Ltd	Equity	₹1.47 Cr	0.73%
GlaxoSmithKline Pharmaceuticals Ltd	Equity	₹1.43 Cr	0.72%
Narayana Hrudayalaya Ltd	Equity	₹1.43 Cr	0.71%
Regeneron Pharmaceuticals Inc	Equity	₹1.13 Cr	0.57%
Anthem Biosciences Ltd	Equity	₹0.96 Cr	0.48%
Becton Dickinson & Co	Equity	₹0.73 Cr	0.37%
IQVIA Holdings Inc	Equity	₹0.6 Cr	0.30%
Agilent Technologies Inc	Equity	₹0.59 Cr	0.30%
Waters Corp	Equity	₹0.55 Cr	0.28%
Net Receivables/(Payables)	Cash - Collateral	₹0.19 Cr	0.09%
Clearing Corporation Of India Ltd.	Cash - Repurchase Agreement	₹0.05 Cr	0.03%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹199.38 Cr	99.88%

Risk & Performance Ratios

Fund Managers

Bhavesh Jain

Since October 2021

Amit Vora

Since February 2021

Manasi Jalgaonkar

Since April 2026

Additional Scheme Detailsas of 31st August 2026

ISIN

INF754K01LV5

Expense Ratio

0.54%

Exit Load

No Charges

Fund Size

₹200 Cr

Age

5 years 10 months

Lumpsum Minimum

₹100

Fund Status

Open Ended Investment Company

Benchmark

MSCI Ind Dom & Wld HealthC 45 NR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Index Funds Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
HDFC BSE REITS and Commercial Real Estate Index Fund Regular Growth Very High Risk	-	0.0%	-	-
HDFC BSE REITS and Commercial Real Estate Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Kotak Nifty Capital Markets Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Kotak Nifty Capital Markets Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Invesco India Nifty Chemical Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Axis Nifty500 Low Volatility 50 Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Axis Nifty500 Low Volatility 50 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Invesco India Nifty Chemical Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Mirae Asset BSE Information Technology Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Mirae Asset BSE Information Technology Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Navi Nifty REITs & Realty Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Navi Nifty REITs & Realty Index Fund Regular Growth Very High Risk	-	0.0%	-	-
UTI BSE India Sector Leaders Index Fund Regular Growth Very High Risk	-	0.0%	-	-
UTI BSE India Sector Leaders Index Fund Direct Growth Very High Risk	-	0.0%	-	-
UTI BSE India Sector Leaders Exchange Traded Fund Very High Risk	-	-	-	-
JioBlackRock Nifty Next 50 Index Fund Regular Growth Very High Risk	-	0.0%	₹222.60 Cr	-
JioBlackRock Nifty 50 Index Fund Regular Growth Very High Risk	-	0.0%	₹268.06 Cr	-
JioBlackRock Nifty Midcap 150 Index Fund Regular Growth Very High Risk	-	0.0%	₹287.17 Cr	-
JioBlackRock Nifty Smallcap 250 Index Fund Regular Growth Very High Risk	-	0.0%	₹404.18 Cr	-
Mirae Asset BSE LargeMid (60 40) Stable Dividend 50 ETF Very High Risk	-	-	-	-
UTI Nifty 500 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
UTI Nifty 500 Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Axis Nifty Energy Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Axis Nifty Energy Index Fund Direct Growth Very High Risk	-	0.0%	-	-
JioBlackRock Nifty 50 ETF Very High Risk	-	-	-	-
Kotak Nifty Bank Index Fund Regular Growth Very High Risk	0.5%	0.0%	-	-
Kotak Nifty Bank Index Fund Direct Growth Very High Risk	0.2%	0.0%	-	-
Edelweiss Nifty REITs & Realty Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Edelweiss Nifty REITs & Realty Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Mirae Asset Nifty200 Momentum 30 Plus 8-13yr G-Sec 75:25 Direct Growth High Risk	0.1%	0.0%	₹13.44 Cr	-
Mirae Asset Nifty200 Momentum 30 Plus 8-13yr G-Sec 75:25 Regular Growth High Risk	0.7%	0.0%	₹13.44 Cr	-
Mirae Asset BSE Midcap 150 Momentum 30 ETF Very High Risk	0.3%	-	₹77.82 Cr	-
Edelweiss Nifty Metal ETF Very High Risk	0.3%	-	₹7.48 Cr	-
Motilal Oswal BSE Midcap 150 Momentum 30 Index Fund Regular Growth Very High Risk	1.1%	1.0%	₹38.02 Cr	-
Motilal Oswal BSE Midcap 150 Momentum 30 Index Fund Direct Growth Very High Risk	0.5%	1.0%	₹38.02 Cr	-
Axis Nifty50 Equal Weight Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹98.21 Cr	-
Axis Nifty50 Equal Weight Index Fund Regular Growth Very High Risk	1.1%	0.0%	₹98.21 Cr	-
HDFC Nifty Auto Index Fund Regular Growth Very High Risk	0.9%	0.0%	₹162.79 Cr	-
HDFC Nifty Auto Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹162.79 Cr	-
Motilal Oswal BSE Clean Environment Index Fund Regular Growth Very High Risk	25.2%	1.0%	₹47.05 Cr	-
Motilal Oswal BSE Clean Environment Index Fund Direct Growth Very High Risk	24.5%	1.0%	₹47.05 Cr	-
Groww Nifty Smallcap 250 Momentum Quality 100 Index Fund Regular Growth Very High Risk	3.3%	0.0%	₹8.67 Cr	-
Kotak Nifty Alpha Low-Volatility 30 Index Fund Regular Growth Very High Risk	2.5%	0.0%	₹7.33 Cr	-
Kotak Nifty Alpha Low-Volatility 30 Index Fund Direct Growth Very High Risk	1.9%	0.0%	₹7.33 Cr	-
Groww Nifty Smallcap 250 Momentum Quality 100 Index Fund Direct Growth Very High Risk	2.7%	0.0%	₹8.67 Cr	-
SBI Nifty G-sec Jul 2031 Index Fund Regular Growth Moderate Risk	0.4%	0.0%	₹17.28 Cr	-
SBI Nifty G-sec Jul 2031 Index Fund Direct Growth Moderate Risk	0.2%	0.0%	₹17.28 Cr	-
Groww Nifty Private Bank Index Fund Regular Growth Very High Risk	2.3%	0.0%	₹5.65 Cr	-
Groww Nifty Private Bank Index Fund Direct Growth Very High Risk	1.6%	0.0%	₹5.65 Cr	-
Axis Nifty Capital Markets Index Fund Regular Growth Very High Risk	2.6%	0.0%	₹125.01 Cr	-

About the AMC

Edelweiss Mutual Fund

+91 22 40979900

https://www.edelweissmf.com/

Total AUM

₹2,25,354 Cr

Address

J.P.Morgan Tower, Mumbai, 400 098

Other Funds by Edelweiss Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Edelweiss Ultra Short Term Fund Direct Growth Low to Moderate Risk	-	0.0%	-	-
Edelweiss Nifty REITs & Realty Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Edelweiss Nifty LargeMidcap250 Plus 8-13 yr G-Sec 70:30 Index Fund Direct Growth Very High Risk	0.8%	0.0%	₹56.71 Cr	-
Edelweiss Gold ETF FoF Direct Growth Very High Risk	0.1%	0.0%	₹52.66 Cr	-
Edelweiss Financial Services Fund Direct Growth Very High Risk	1.0%	1.0%	₹288.89 Cr	-
Edelweiss Silver ETF Fund of Fund Direct Growth Very High Risk	0.1%	-	₹107.41 Cr	-
Altiva Hybrid Long-Short Fund Direct Growth Low to Moderate Risk	1.2%	0.0%	₹7009.59 Cr	-
Edelweiss Multi Asset Omni Fund of Fund Direct Growth Very High Risk	0.2%	1.0%	₹532.41 Cr	11.6%
Edelweiss Income Plus Arbitrage Active Fund of Funds Direct Growth Low to Moderate Risk	0.1%	0.0%	₹124.45 Cr	5.8%
Edelweiss BSE Internet Economy Index Fund Direct Growth Very High Risk	0.6%	0.0%	₹40.66 Cr	6.0%
Edelweiss Low Duration Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹500.83 Cr	6.3%
Edelweiss CRISIL-IBX AAA Bond NBFC-HFC - Jun 2027 Index Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹81.25 Cr	6.6%
Edelweiss Consumption Fund Direct Growth Very High Risk	0.9%	1.0%	₹492.58 Cr	-6.1%
Edelweiss CRISIL IBX AAA Financial Services - Jan 2028 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹103.32 Cr	6.1%
Edelweiss Nifty500 Multicap Momentum Quality 50 Index Fund Direct Growth Very High Risk	0.9%	0.0%	₹625.99 Cr	-4.4%
Edelweiss Business Cycle Fund Direct Growth Very High Risk	1.4%	1.0%	₹1463.37 Cr	2.4%
Edelweiss Nifty Alpha Low Volatility 30 Index Fund Direct Growth Very High Risk	0.8%	0.0%	₹92.34 Cr	-2.7%
Edelweiss Technology Fund Direct Growth Very High Risk	0.8%	1.0%	₹810.43 Cr	5.7%
Edelweiss Silver ETF Regular Growth Very High Risk	0.5%	-	₹1862.79 Cr	79.8%
Edelweiss Multi Cap Fund Direct Growth Very High Risk	0.7%	1.0%	₹3550.33 Cr	3.8%
Edelweiss Banking and PSU Debt Fund Direct Growth Moderate Risk	0.4%	0.0%	₹3139.98 Cr	4.9%
Edelweiss NIFTY Large Midcap 250 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹354.03 Cr	-1.0%
Edelweiss Money Market Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹2322.39 Cr	6.6%
Edelweiss Liquid Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹13272.23 Cr	6.5%
Edelweiss Mid Cap Fund Direct Growth Very High Risk	0.7%	1.0%	₹19891.00 Cr	5.5%
Edelweiss Greater China Equity Direct Growth Very High Risk	1.5%	1.0%	₹3078.85 Cr	24.2%
Edelweiss ASEAN Equity Off Shore Direct Growth Very High Risk	1.6%	1.0%	₹164.77 Cr	18.1%
Edelweiss Large & Mid Cap Fund Direct Growth Very High Risk	0.7%	1.0%	₹4942.41 Cr	2.4%
Edelweiss CRISIL PSU Plus SDL 50:50 Oct 2025 Index Fund Direct Growth Low Risk	0.2%	0.0%	₹565.05 Cr	6.7%
Edelweiss Europe Dynamic Equity Offshore Fund Direct Growth Very High Risk	1.5%	1.0%	₹282.80 Cr	25.0%
BHARAT Bond FOF April 2030 Direct Growth Moderate Risk	0.0%	0.0%	₹8868.24 Cr	4.4%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹128.70 Cr	5.4%
Edelweiss Flexi Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹3721.74 Cr	-0.3%
Edelweiss Overnight Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹192.18 Cr	5.3%
Edelweiss Multi Asset Allocation Fund Direct Growth High Risk	0.8%	0.0%	₹2953.76 Cr	6.5%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹199.62 Cr	19.4%
Edelweiss Long Term Equity Fund Direct Growth Very High Risk	0.9%	0.0%	₹462.33 Cr	3.2%
Edelweiss Recently Listed IPO Fund Direct Growth Very High Risk	1.1%	2.0%	₹1230.36 Cr	16.0%
Edelweiss Balanced Advantage Fund Direct Growth Very High Risk	1.0%	1.0%	₹13445.00 Cr	3.4%
Edelweiss Government Securities Fund Direct Growth Moderate Risk	0.5%	0.0%	₹123.12 Cr	1.6%
Edelweiss Small Cap Fund Direct Growth Very High Risk	0.7%	1.0%	₹7252.91 Cr	6.3%
Edelweiss Nifty Smallcap 250 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹284.59 Cr	3.4%
Edelweiss Nifty Midcap150 Momentum 50 Index Fund Direct Growth Very High Risk	1.1%	0.0%	₹1833.83 Cr	1.4%
Edelweiss Nifty Next 50 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹302.84 Cr	3.6%
Edelweiss Large Cap Fund Direct Growth Very High Risk	1.0%	1.0%	₹1434.03 Cr	-2.9%
Edelweiss Aggressive Hybrid Fund Direct Growth Very High Risk	0.8%	1.0%	₹3997.70 Cr	0.7%
Edelweiss Focused Equity Fund Direct Growth Very High Risk	0.8%	1.0%	₹1050.81 Cr	-1.5%
Edelweiss Nifty PSU Bond Plus SDL Apr 2027 50:50 Index Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹2121.80 Cr	6.1%
BHARAT Bond FOF April 2025 Direct Growth Low to Moderate Risk	0.1%	0.0%	₹4072.13 Cr	7.7%
BHARAT Bond FOF April 2031 Direct Growth Moderate Risk	0.0%	0.0%	₹4587.38 Cr	3.9%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Dezerv

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth?

The NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth, as of 16-Sep-2026, is ₹24.41.

What are the returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth?

The fund has generated 19.38% over the last 1 year and 18.46% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth?

The fund's allocation of assets is distributed as 99.88% in equities, 0.00% in bonds, and 0.12% in cash and cash equivalents.

Who manages the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth?

The fund managers responsible for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth are:-

Bhavesh Jain
Amit Vora
Manasi Jalgaonkar

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2026 Dezerv. All Rights Reserved

Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

Fund Overview